ML 18 from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
ML 18

Description

ML 18 is a bombesin receptor subtype 3 (BRS-3) antagonist (IC50 = 4.8 µM) and binds GRPR (IC50 = 16 µM) with potential in combating lung cancer cells